(Q46669648)
Statements
1 reference
A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors (English)
1 reference
Debashis Sarker
1 reference
Rhoda Molife
1 reference
T R Jeffrey Evans
1 reference
Maryon Hardie
1 reference
Cheryl Marriott
1 reference
Priska Butzberger-Zimmerli
1 reference
Rosemary Morrison
1 reference
Judith A Fox
1 reference
Carla Heise
1 reference
Sharianne Louie
1 reference
Natasha Aziz
1 reference
Felix Garzon
1 reference
Glenn Michelson
1 reference
Ian R Judson
1 reference
Dalal Jadayel
1 reference
Edgar Braendle
1 reference
Johann S de Bono
1 reference
1 April 2008
1 reference
14
1 reference
7
1 reference
2075-2081
1 reference